Xynomic Pharmaceutical Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
Frequently Asked Questions
What is Market Cap of Bison Capital Acquisition Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Bison Capital Acquisition Corp market cap is N/A.
What is the 52-week high for Bison Capital Acquisition Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bison Capital Acquisition Corp 52 week high is N/A as of September 14, 2025.
What is the 52-week low for Bison Capital Acquisition Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bison Capital Acquisition Corp 52 week low is N/A as of September 14, 2025.
What is Bison Capital Acquisition Corp stock price today?
Bison Capital Acquisition Corp stock price today is $2.45.
What was Bison Capital Acquisition Corp stock price yesterday?
Bison Capital Acquisition Corp stock price yesterday was $2.40.
What is the PE ratio of Bison Capital Acquisition Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Bison Capital Acquisition Corp’s P/E ratio is None.
What is the Price-to-Book ratio of Bison Capital Acquisition Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Bison Capital Acquisition Corp P/B ratio is None.
What is Bison Capital Acquisition Corp's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Bison Capital Acquisition Corp's EBITDA is N/A.
What is the 50-day moving average of Bison Capital Acquisition Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Bison Capital Acquisition Corp 50-day moving average is N/A.
How many employess does Bison Capital Acquisition Corp has?